Melanóma: vizsgálatok itt: Kína

In Kína 70 Also abroad 579

70 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.

1. fázisTaking people
A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors
Where
Fuzhou, Hangzhou, Luoyang, Tianjin, Wenzhou, Wuhan, Xi'an
Életkor
18 év to 70 év
People
174
Run by
Shanghai Henlius Biotech
See details and how to joinNCT07518043
1. fázisCsak meghívásos
A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma
Where
Beijing
Életkor
18 év and over
People
60
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT06424626
2. fázisTaking people
A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.
Where
Shanghai
Életkor
18 év to 80 év
People
95
Run by
Fudan University
See details and how to joinNCT06889610
1. fázisTaking people
A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies
Where
Changchun, Changsha, Fuzhou, Guangzhou, Hangzhou, Harbin, Kunming, Luoyang, Nanchang, Shanghai, Shenyang, Wuhan
Életkor
18 év and over
People
214
Run by
Shanghai Junshi Bioscience Co., Ltd.
See details and how to joinNCT06839105
1. fázisTaking people
A Study of DEG6498 in Participants With Solid Tumors
Where
Beijing, Guangzhou
Életkor
18 év and over
People
100
Run by
Degron Therapeutics Co.
See details and how to joinNCT07244835
No phaseNot yet taking people in Kína
CLASSIFY-OMM: Multicenter Rare Disease Cohort for T-Stage Reclassification and Molecular Subtyping-Based Precision Therapy in Oral Mucosal Melanoma
Where
Shanghai
Életkor
18 év and over
People
1100
Run by
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
See details and how to joinNCT07662694
2. fázisTaking people
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma
Where
Guangzhou, Shenzhen
Életkor
60 év and over
People
55
Run by
Sun Yat-sen University
See details and how to joinNCT07644897
1/2. fázisTaking people
Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma
Where
Shenzhen
Életkor
18 év to 75 év
People
36
Run by
Beijing Biotech
See details and how to joinNCT07627698
No phaseTaking people
Exploratory Study With Parallel Controls on the Safety and Efficacy of Neoadjuvant Low Branched-Chain Amino Acid Diet in Combination With Anti-PD-1 Monoclonal Antibody for Stage III Melanoma
Where
Xi’an
Életkor
18 év to 75 év
People
80
Run by
Xijing Hospital
See details and how to joinNCT07586891
Korai 1. fázisTaking people
Efficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon α1b in Stage III/IV Melanoma.
Where
Xi'an
Életkor
18 év to 75 év
People
10
Run by
Xijing Hospital
See details and how to joinNCT07586904
No phaseTaking people
Liquid Biopsy Multi-Omics and Biomarker Development in Melanoma
Where
Xi’an
Életkor
18 év to 80 év
People
200
Run by
Xijing Hospital
See details and how to joinNCT07584291
No phaseTaking people
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
Where
Wuhan
Életkor
18 év and over
People
26
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07552467
1/2. fázisTaking people
HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours
Where
Beijing
Életkor
18 év to 70 év
People
124
Run by
Hangzhou Hanx Biopharmaceuticals, Ltd.
See details and how to joinNCT06708663
4. fázisTaking people
RWS of Tunlametinib in NRAS-Mutant Advanced Melanoma
Where
Shanghai
Életkor
18 év and over
People
110
Run by
Fudan University
See details and how to joinNCT07445022
1/2. fázisTaking people
Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
Where
Beijing
Életkor
8 év to 85 év
People
85
Run by
Essen Biotech
See details and how to joinNCT07410494
1/2. fázisTaking people
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
Where
Beijing
People
83
Run by
Essen Biotech
See details and how to joinNCT07410676
1. fázisTaking people
A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors
Where
Shanghai
Életkor
18 év and over
People
194
Run by
Hefei TG ImmunoPharma Co., Ltd.
See details and how to joinNCT07376707
1/2. fázisTaking people
An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
Where
Beijing, Hangzhou, Zhengzhou
Életkor
18 év and over
People
266
Run by
Beijing Tide Pharmaceutical Co., Ltd
See details and how to joinNCT07371663
2. fázisNot yet taking people in Kína
A Prospective, Single-Arm, Phase II Clinical Study of Neoadjuvant Therapy With Pucotenlimab, Lenvatinib, and Temozolomide for Resectable Head and Neck Mucosal Melanoma (PLT-NAT-HNMM-II)
Where
Shanghai
Életkor
18 év to 75 év
People
30
Run by
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
See details and how to joinNCT07353073
2. fázisNot yet taking people in Kína
Iparomlimab and Tuvoraleimab Injection in Combination With Bevacizumab, Albumin-bound Paclitaxel, and Carboplatin as First- or Second-line Treatment for Patients With Advanced Acral and Mucosal Melanoma
Where
Shanghai
Életkor
18 év to 75 év
People
48
Run by
Fudan University
See details and how to joinNCT07347444
2. fázisTaking people
Paclitaxel Polymersomes + Carboplatin + Adebelimab: Neoadjuvant Phase Ⅱ Single-Arm Study for Resectable Mucosal Melanoma
Where
Guangzhou
Életkor
18 év and over
People
32
Run by
Sun Yat-sen University
See details and how to joinNCT07336979
Korai 1. fázisTaking people
A Study of GC101 TIL in Advanced Melanoma (10hospital)
Where
Shanghai
Életkor
18 év to 75 év
People
50
Run by
Shanghai Juncell Therapeutics
See details and how to joinNCT05098184
1/2. fázisTaking people
Study of GV20-0251 in Participants With Solid Tumor Malignancies
Where
Beijing, Shanghai
Életkor
18 év and over
People
350
Run by
GV20 Therapeutics
See details and how to joinNCT07070518
1. fázisTaking people
VSV-02 Compassionate Use in Advanced Solid Tumors
Where
Xinxiang
Életkor
18 év and over
People
6
Run by
The First Affiliated Hospital of Xinxiang Medical College
See details and how to joinNCT07260591
1. fázisTaking people
A Study of GV20-0251 in Advanced or Refractory Solid Tumors
Where
Chengdu
Életkor
18 év and over
People
10
Run by
West China Hospital
See details and how to joinNCT07106827